CD164 Protein (CD164) (AA 24-162) (hFc Tag)
Quick Overview for CD164 Protein (CD164) (AA 24-162) (hFc Tag) (ABIN7274215)
Target
See all CD164 ProteinsProtein Type
Biological Activity
Origin
Source
Purity
-
-
Protein Characteristics
- AA 24-162
-
Purification tag / Conjugate
- This CD164 protein is labelled with hFc Tag.
-
Purpose
- Mouse CD164 Protein
-
Sequence
- Gln24-Asp162
-
Characteristics
- Recombinant Mouse CD164 Protein is expressed from HEK293 with hFc (IgG1) tag at the C-Terminus.It contains Gln24-Asp162.
-
Sterility
- 0.22 μm filtered
-
Endotoxin Level
- Less than 1 EU per μg by the LAL method.
-
Biological Activity Comment
- Mouse CD164 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.,The purity of Mouse CD164 is greater than 95% as determined by SEC-HPLC.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 μg or less, at 1 mg/mL for 500 μg or 1 mg lyophilized powder. Do not mix by vortex or vigorous shaking.
-
Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3 months after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- CD164
-
Alternative Name
- CD164
-
Background
- CD164 was found to play a role in many malignant diseases. CD164 was associated with clinical and pathological features of patients. High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients.CD164 was associated with the poor clinical outcomes of BC patients. Silencing of CD164 could inhibit the progression of tumors in vivo and in vitro, which may become an effective target in the treatment of bladder cancer.
-
Molecular Weight
- 41.4 kDa. Due to glycosylation, the protein migrates to 70-115 kDa based on Bis-Tris PAGE result.
-
UniProt
- Q9R0L9
Target
-